GBT logo

GBT Long Term Liabilities

Annual Total Long Term Liabilities

$654.80 M
+$425.99 M+186.17%

December 31, 2021


Summary


Performance

GBT Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Quarterly Long Term Liabilities

$658.99 M
+$2.75 M+0.42%

June 30, 2022


Summary


Performance

GBT Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

GBT Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+186.2%+190.9%
3 y3 years+5814.6%+2543.5%
5 y5 years+5519.6%+10000.0%

GBT Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high-0.6%
5 y5-yearat high-77.7%at high-77.9%
alltimeall timeat high-99.9%at high-99.9%

Global Blood Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Jun 2022
-
$658.99 M(+0.4%)
Mar 2022
-
$656.24 M(+0.2%)
Dec 2021
$654.80 M(+186.2%)
$654.80 M(+190.6%)
Sep 2021
-
$225.32 M(-0.5%)
Jun 2021
-
$226.53 M(-0.5%)
Mar 2021
-
$227.74 M(-0.5%)
Dec 2020
$228.81 M(+56.8%)
$228.81 M(+47.0%)
Sep 2020
-
$155.66 M(-0.5%)
Jun 2020
-
$156.45 M(+0.7%)
Mar 2020
-
$155.33 M(+6.4%)
Dec 2019
$145.95 M(+1218.3%)
$145.95 M(+420.2%)
Sep 2019
-
$28.06 M(+12.6%)
Jun 2019
-
$24.93 M(+2.0%)
Mar 2019
-
$24.43 M(+120.7%)
Dec 2018
$11.07 M
$11.07 M(-1.9%)
Sep 2018
-
$11.28 M(-1.0%)
DateAnnualQuarterly
Jun 2018
-
$11.40 M(-2.2%)
Mar 2018
-
$11.65 M(0.0%)
Dec 2017
$11.65 M(+1969.6%)
$11.65 M(+23.5%)
Sep 2017
-
$9.43 M(+212.5%)
Jun 2017
-
$3.02 M(+590.8%)
Mar 2017
-
$437.00 K(-22.4%)
Dec 2016
$563.00 K(-63.8%)
$563.00 K(-27.4%)
Sep 2016
-
$775.00 K(-37.1%)
Jun 2016
-
$1.23 M(-9.0%)
Mar 2016
-
$1.35 M(-13.0%)
Dec 2015
$1.56 M(-98.5%)
$1.56 M(-5.4%)
Sep 2015
-
$1.65 M(-98.5%)
Jun 2015
-
$107.17 M(>+9900.0%)
Mar 2015
-
$371.00 K(-99.6%)
Dec 2014
$102.55 M(+261.3%)
$102.55 M
Dec 2013
$28.39 M
-

FAQ

  • What is Global Blood Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual total long term liabilities year-on-year change?
  • What is Global Blood Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly long term liabilities year-on-year change?

What is Global Blood Therapeutics annual total long term liabilities?

The current annual total long term liabilities of GBT is $654.80 M

What is the all time high annual total long term liabilities for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual total long term liabilities is $654.80 M

What is Global Blood Therapeutics annual total long term liabilities year-on-year change?

Over the past year, GBT annual total long term liabilities has changed by +$425.99 M (+186.17%)

What is Global Blood Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of GBT is $658.99 M

What is the all time high quarterly long term liabilities for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly total long term liabilities is $658.99 M

What is Global Blood Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, GBT quarterly total long term liabilities has changed by +$432.46 M (+190.90%)